Sangamo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	57.8	176.23	111.3	110.7	118.19	Upgrade
Revenue Growth (YoY)	-67.20%	58.34%	0.54%	-6.34%	15.39%	Upgrade
Cost of Revenue	111.52	230.46	249.9	230.82	180.65	Upgrade
Gross Profit	-53.72	-54.23	-138.6	-120.12	-62.46	Upgrade
Selling, General & Admin	44.63	60.07	62.68	63.22	67.1	Upgrade
Operating Expenses	44.63	60.07	62.68	63.22	67.1	Upgrade
Operating Income	-98.35	-114.29	-201.28	-183.34	-129.55	Upgrade
Interest & Investment Income	8.2	8.25	6.43	5.35	8.78	Upgrade
Currency Exchange Gain (Loss)	-2.94	2.85	-	-	-	Upgrade
EBT Excluding Unusual Items	-93.09	-103.19	-194.85	-177.99	-120.78	Upgrade
Merger & Restructuring Charges	-0.1	-4.7	-	-	-	Upgrade
Impairment of Goodwill	-	-38.14	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	0.6	-	-	-	-	Upgrade
Asset Writedown	-5.52	-116.88	-	-	-	Upgrade
Other Unusual Items	-	-	3	-	-	Upgrade
Pretax Income	-98.11	-262.9	-191.85	-177.99	-120.78	Upgrade
Income Tax Expense	-0.17	-5.07	0.43	0.31	0.35	Upgrade
Earnings From Continuing Operations	-97.94	-257.83	-192.28	-178.3	-121.12	Upgrade
Minority Interest in Earnings	-	-	-	0.01	0.13	Upgrade
Net Income	-97.94	-257.83	-192.28	-178.29	-121	Upgrade
Net Income to Common	-97.94	-257.83	-192.28	-178.29	-121	Upgrade
Shares Outstanding (Basic)	202	174	154	145	134	Upgrade
Shares Outstanding (Diluted)	202	174	154	145	134	Upgrade
Shares Change (YoY)	15.62%	13.02%	6.76%	7.53%	19.92%	Upgrade
EPS (Basic)	-0.49	-1.48	-1.25	-1.23	-0.90	Upgrade
EPS (Diluted)	-0.49	-1.48	-1.25	-1.23	-0.90	Upgrade
Free Cash Flow	-67.41	-246	-243.8	-256.53	155.16	Upgrade
Free Cash Flow Per Share	-0.33	-1.41	-1.58	-1.77	1.15	Upgrade
Gross Margin	-92.94%	-30.77%	-124.53%	-108.51%	-52.84%	Upgrade
Operating Margin	-170.15%	-64.85%	-180.85%	-165.62%	-109.61%	Upgrade
Profit Margin	-169.45%	-146.30%	-172.76%	-161.05%	-102.37%	Upgrade
Free Cash Flow Margin	-116.62%	-139.59%	-219.05%	-231.73%	131.28%	Upgrade
EBITDA	-93.24	-99.23	-189.17	-173.9	-123.87	Upgrade
EBITDA Margin	-161.32%	-56.31%	-169.97%	-157.09%	-104.80%	Upgrade
D&A For EBITDA	5.11	15.07	12.11	9.44	5.68	Upgrade
EBIT	-98.35	-114.29	-201.28	-183.34	-129.55	Upgrade
EBIT Margin	-170.15%	-64.85%	-180.85%	-165.61%	-109.61%	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q